CATALOGO DEI PRODOTTI DELLA RICERCA

TINAZZI MARTINI GOBBO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.905
NA - Nord America 4.469
AS - Asia 2.877
SA - Sud America 359
AF - Africa 46
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.666
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.410
GB - Regno Unito 1.609
CN - Cina 1.186
IT - Italia 1.139
SG - Singapore 1.017
SE - Svezia 435
HK - Hong Kong 364
DE - Germania 332
BR - Brasile 320
FR - Francia 319
RU - Federazione Russa 306
IE - Irlanda 272
FI - Finlandia 252
KR - Corea 80
UA - Ucraina 75
NL - Olanda 53
CA - Canada 43
VN - Vietnam 43
TR - Turchia 41
JP - Giappone 40
BE - Belgio 28
IN - India 22
PL - Polonia 16
IR - Iran 14
AT - Austria 13
BD - Bangladesh 13
ES - Italia 13
AR - Argentina 12
TG - Togo 10
ID - Indonesia 9
CZ - Repubblica Ceca 8
EC - Ecuador 8
ZA - Sudafrica 8
DZ - Algeria 6
KE - Kenya 6
LT - Lituania 6
IL - Israele 5
IQ - Iraq 5
MX - Messico 5
PK - Pakistan 5
AU - Australia 4
AZ - Azerbaigian 4
CH - Svizzera 4
CL - Cile 4
EU - Europa 4
MA - Marocco 4
RS - Serbia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AM - Armenia 3
CI - Costa d'Avorio 3
CO - Colombia 3
IM - Isola di Man 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
LV - Lettonia 3
MT - Malta 3
PE - Perù 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KZ - Kazakistan 2
MY - Malesia 2
PY - Paraguay 2
SA - Arabia Saudita 2
AI - Anguilla 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GN - Guinea 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
Totale 12.666
Salva come PNG Salva come JPEG
Città #
Southend 1.473
Chandler 646
Jacksonville 621
Singapore 482
Dallas 454
Hong Kong 362
Ann Arbor 327
Woodbridge 300
Dublin 270
Ashburn 230
Beijing 204
Jinan 111
Houston 106
Wilmington 105
Lawrence 100
Princeton 100
Nanjing 95
Verona 88
Munich 85
Milan 81
New York 76
Shenyang 76
Rome 71
Los Angeles 65
Helsinki 63
The Dalles 56
Hebei 53
Tianjin 44
Zhengzhou 41
Lancaster 40
Columbus 39
São Paulo 38
Taizhou 37
Bologna 36
Sindelfingen 36
Dearborn 33
Guangzhou 33
Haikou 33
Changsha 32
Tokyo 32
Ningbo 30
Taiyuan 29
Turku 29
Santa Clara 28
Brussels 27
Buffalo 25
San Francisco 23
Seoul 20
Nanchang 19
Council Bluffs 18
Boardman 17
Seattle 17
Redwood City 16
Toronto 16
Jiaxing 15
Norwalk 14
Nuremberg 14
Palermo 14
Redmond 14
Rio de Janeiro 14
Moscow 13
Washington 13
Bari 12
Falls Church 12
Hangzhou 12
Ho Chi Minh City 12
Chicago 11
Lanzhou 11
Montreal 11
Naples 11
Dongguan 10
Düsseldorf 10
Kent 10
Lomé 10
Florence 9
Frankfurt am Main 9
London 9
Phoenix 9
Vienna 9
Amsterdam 8
Brescia 8
Clearwater 8
Fuzhou 8
Genova 8
Hanoi 8
Turin 8
Warsaw 8
Augusta 7
Bolzano 7
Catania 7
Peschiera del Garda 7
Redondo Beach 7
Saint Louis 7
Wuhan 7
Brasília 6
Johannesburg 6
Legnaro 6
Madrid 6
Nairobi 6
Qingdao 6
Totale 7.925
Salva come PNG Salva come JPEG
Nome #
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 598
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 315
CLEAR CELL-PAPILLARY RENAL CELL CARCINOMA 286
Schwannoma del rene 200
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 194
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 179
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 178
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 175
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 162
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 161
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 155
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 155
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 150
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 148
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 146
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 145
Chondroid syringoma with extensive ossification 145
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 142
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 141
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 137
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 132
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 132
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 131
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 129
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 128
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 127
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 124
[Diagnostic and prognostic markers in renal tumors] 122
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 122
Correlation of MR features and histogram-derived parameters with aggressiveness and outcomes after resection in pancreatic ductal adenocarcinoma 122
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 121
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 121
Espressione di CD23 nelle neoplasie cutanee annessiali 120
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 119
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 119
Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization 119
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 118
Carcinomi renali papillari con aree di cellule chiare 117
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 117
Clear-Cell Papillary Renal cell Carcinoma: a Distinct Histopathological and Molecular Genetic Entity 117
Subepithelial Pelvic Hematoma (Antopol-Goldman Lesion) Simulating Renal Neoplasm: Report of a Case and Review of the Literature 116
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 115
Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies 115
Expression of GATA-3 among renal cell and urothelial neoplasms 114
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 114
ESGAR 2016 Book of Abstracts 114
La perdita del 9p è un fattore prognostico nei pazienti affetti da carcinoma a cellule chiare del rene 113
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 112
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma 111
Patterns of 1p/19q chromosomal abnormalities among glial neoplasms 111
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 111
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 111
S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma 110
Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas 108
Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy 108
Significato prognostico della perdita del cromosoma 9P nei carcinomi renali a cellule chiare stratificati per UISS e SSIGN score 108
Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms: 10-year experience with more than 2,000 cases and a review of the literature 108
Serous Neoplasms 108
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 108
Interphase Cytogenetic in Metastatic Chromophobe Renal Cell Carcinoma (RCC) 107
Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors 105
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 105
Marcatori Diagnostici e Prognostici nei Tumori Renali 103
Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma 103
Giant Brunner's gland adenoma 99
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 99
S100A1 ed S100 nella diagnosi differenziale delle neoplasie epiteliali del rene 97
Neuroendocrine Neoplasm 97
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 97
Utilità del tissue microarray nella valutazione delle anomalie cromosomiche del carcinoma renale di tipo cromofobo 95
Uncommon presentations of common pancreatic neoplasms: a pictorial essay 94
Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 93
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 93
Cathepsin-k expression in pulmonary lymphangioleiomyomatosis 92
Tumour thrombosis: an uncommon finding associated with pancreas tumours 92
Human aspartic protein napsin-A: immunoistochemical detection among renal cell neoplasms 89
Immunohistochemical profile of common epithelial neoplasms arising in the kidney 89
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 89
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging 88
Hybrid Tumors, Oncocytomas and Chromophobe Renal Cell Carcinomas, , 2005 87
PROGNOSTIC ROLE OF CHROMOSOME 9P DELETION IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA 87
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 87
Periorbital subcutaneous tumor-like lesion due to Dirofilaria repens 85
Fluorescent cytogenetics of renal cell neoplasms 85
Primary pleomorphic rhabdomyosarcoma of the kidney in an adult. 84
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 84
Utility of tissue microarrays for assessment of diagnostic chromosomal abnormalities in chromophobe renal cell carcinoma 83
Tumour thrombosis: an uncommon finding associated with pancreatic tumours 83
Schwannoma of the kidney 80
FISH Scoring on Paraffin Sections Versus Single-cell Suspension for Chromophobe Renal Carcinoma and Renal Oncocytoma 80
Clear Cell Papillary Renal Cell Carcinoma-like Tumors in Patients With Von Hippel-Lindau Disease Are Unrelated to Sporadic Clear Cell Papillary Renal Cell Carcinoma. 79
Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation 78
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 76
Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors 75
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 67
iForensic, multicentric validation of digital whole slide images (WSI) in forensic histopathology setting according to the College of American Pathologists guidelines 66
Prognostic role of the histological subtypes of renal cell carcinoma after slide revision 65
Clear-cell papillary renal cell carcinoma: a distinct histopathological and molecular genetic entity 65
Neuroendocrine Neoplasms 64
Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations 62
Totale 12.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.288
article - articoli 28.207
book - libri 0
conference - conferenze 15.338
curatela - curatele 0
other - altro 619
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.124
Totale 90.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021902 0 0 47 131 175 96 46 89 73 26 140 79
2021/2022996 119 281 12 96 56 50 14 46 25 24 94 179
2022/20231.972 129 219 188 303 194 454 36 126 194 34 50 45
2023/20241.054 44 82 95 114 115 144 58 73 30 47 186 66
2024/20252.655 136 146 148 438 119 98 107 133 356 202 271 501
2025/20261.335 533 391 411 0 0 0 0 0 0 0 0 0
Totale 12.824